AnalystsChase KnickerbockerChase Knickerbocker's Stock Forecasts
AnalystsChase Knickerbocker
Analyst Ranking
Top 6%
#298 out of 5283 analysts
Average Return
+39.11%
Win Rate
68%39 out of 57
Risk vs Reward
Poor
Good
Chase Knickerbocker's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eton Pharmaceuticals IncETON | +352.53% | $3.75 | $16.97 | 2024-05-05 - 2025-05-05 | Buy |
Phathom Pharmaceuticals IncPHAT | +335.14% | $2.76 | $12.01 | 2025-05-01 - 2026-05-01 | Buy |
Indivior Pharmaceuticals IncINDV | +218.77% | $7.46 | $23.78 | 2024-10-10 - 2025-10-10 | Buy |
Neuraxis IncNRXS | +189.29% | $2.52 | $7.29 | 2025-06-15 - 2026-05-28 | Buy |
Eton Pharmaceuticals IncETON | +184.71% | $7.00 | $19.93 | 2024-10-03 - 2025-10-03 | Buy |
Chase Knickerbocker Analyst Color
Get additional color on Chase Knickerbocker's coverage of popular stocks
Chase Knickerbocker's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mimedx Group IncMDXG | 3 | Buy | $7.00 | +90.74% | Maintains | a month ago |
Alpha Cognition IncACOG | 1 | Buy | $14.00 | +135.69% | Initiates Coverage On | a month ago |
Neuraxis IncNRXS | 3 | Buy | $13.00 | +78.33% | Maintains | 2 months ago |
Eton Pharmaceuticals IncETON | 8 | Buy | $35.00 | +9.86% | Maintains | 2 months ago |
Harrow IncHROW | 4 | Buy | $64.00 | +80.84% | Maintains | 8 months ago |
Indivior Pharmaceuticals IncINDV | 5 | Buy | $34.00 | -7.13% | Maintains | 9 months ago |
Scpharmaceuticals IncSCPH | 3 | Hold | $6.00 | +5.82% | Downgrades | 9 months ago |
Fennec Pharmaceuticals IncFENC | 6 | Buy | $14.00 | +41.56% | Maintains | 9 months ago |
Polypid LtdPYPD | 2 | Buy | $13.00 | +173.11% | Maintains | 9 months ago |
Xeris Biopharma Holdings IncXERS | 2 | Buy | $11.00 | +74.05% | Maintains | 10 months ago |
Diamedica Therapeutics IncDMAC | 1 | Buy | $11.00 | +78.57% | Maintains | 10 months ago |
Butterfly Network IncBFLY | 1 | Buy | $3.00 | -34.92% | Initiates Coverage On | a year ago |
Phathom Pharmaceuticals IncPHAT | 3 | Buy | $17.00 | +64.73% | Maintains | a year ago |
Mediwound LtdMDWD | 1 | Buy | $39.00 | N/A | Initiates Coverage On | a year ago |
Ironwood Pharmaceuticals IncIRWD | 4 | Buy | $8.00 | N/A | Maintains | a year ago |
Delcath Systems IncDCTH | 2 | Buy | $21.00 | N/A | Maintains | a year ago |
Koru Medical Systems IncKRMD | 2 | Buy | $6.00 | N/A | Maintains | a year ago |
Grace Therapeutics IncGRCE | 2 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Codere Online Luxembourg SaCDRO | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Avadel Pharmaceuticals PLCAVDL | 2 | Buy | $23.00 | N/A | Maintains | 2 years ago |
Xtant Medical Holdings IncXTNT | 2 | Buy | $1.20 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.